Evidence map›Paper›PMID 31155615›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2019

Variants in MED12L, encoding a subunit of the mediator kinase module, are responsible for intellectual disability associated with transcriptional defect.

Mathilde Nizon, Vincent Laugel, Kevin M Flanigan, Matthew Pastore, Megan A Waldrop, Jill A Rosenfeld, Ronit Marom, Rui Xiao, Amanda Gerard, Olivier Pichon and 12 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Heterozygous Med13l mice recapitulate a developmental growth delay and craniofacial anomalies seen in MED13L syndrome.Developmental dynamics : an official publication of the American Association of Anatomists · 2026
    Article
  3. PASNA syndrome with overlappingJCEM case reports · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Case Report: A novelFrontiers in psychiatry · 2026
    Article
  8. Article
  9. Expanding the Clinical and Molecular Spectrum ofmedRxiv : the preprint server for health sciences · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 12 institutions in 2 countries.

Mathilde NizonCHU Nantes, Service de Génétique Médicale, Nantes, France. bertrand.isidor@chu-nantes.fr.ORCID http://orcid.org/0000-0003-2170-4210
Vincent LaugelLaboratoire de génétique médicale, INSERM UMR 1112, Faculté de Médecine, 11 rue Humann, 67000, Strasbourg, France.
Kevin M FlaniganNeurology Department, Nationwide Children's Hospital, Columbus, OH, USA.
Matthew PastoreNeurology Department, Nationwide Children's Hospital, Columbus, OH, USA.
Megan A WaldropNeurology Department, Nationwide Children's Hospital, Columbus, OH, USA.
Jill A RosenfeldBaylor College of Medicine, Houston, TX, USA.
Ronit MaromBaylor College of Medicine, Houston, TX, USA.
Rui XiaoBaylor College of Medicine, Houston, TX, USA.
Amanda GerardBaylor College of Medicine, Houston, TX, USA.
Olivier PichonCHU Nantes, Service de Génétique Médicale, Nantes, France.
Cédric Le CaignecCHU Nantes, Service de Génétique Médicale, Nantes, France.
Marion GérardService de Génétique Clinique, CHU Caen, Caen, France.
Klaus DieterichService de Génétique Clinique, CHU Grenoble, Grenoble, France.
Megan Truitt ChoClinical Genomics GeneDx, Gaithersburg, MD, USA.
Kirsty McWalterClinical Genomics GeneDx, Gaithersburg, MD, USA.ORCID http://orcid.org/0000-0002-1654-9036
Susan HiattHudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.ORCID http://orcid.org/0000-0001-5214-6747
Michelle L ThompsonHudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
Stéphane BézieauCHU Nantes, Service de Génétique Médicale, Nantes, France.
Alexandrea WadleyUniversity of Oklahoma School of Medicine, Oklahoma City, OK, USA.
Klaas J WierengaMayo Clinic Florida, Jacksonville, FL, 32224, USA.
Jean-Marc EglyInstitut de génétique et de biologie moléculaire cellulaire IGBMC, Faculté de Médecine, Strasbourg, France.
Bertrand IsidorCHU Nantes, Service de Génétique Médicale, Nantes, France.
Baylor College of Medicine · USCentre National de la Recherche Scientifique · FRNationwide Children's Hospital · USGénétique Médicale & Génomique Fonctionelle · FRHudsonAlpha Institute for Biotechnology · USID Genomics (United States) · USCentre Hospitalier Universitaire de Caen Normandie · FRCentre Hospitalier Universitaire de Grenoble · FRInserm · FRInstitut de génétique et de biologie moléculaire et cellulaire · FRUniversity of Oklahoma · USWinnMed · US

Funding

South-seq: DNA sequencing for newborn nurseries in the SouthU01HG007301 · NHGRI · HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY · PI BARSH, GREGORY STEFAN, COOPER, GREGORY MICHAEL · 2017 to 2021
$11.9M
Genomic Diagnosis in Children with Developmental DelayUM1HG007301 · NHGRI · HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY · PI COOPER, GREGORY MICHAEL, MYERS, RICHARD M · 2013 to 2016
$7.5M
NHGRI NIH HHS U01 HG007301NHGRI NIH HHS UM1HG007301
6 · The paper itself

Abstract

purposeMediator is a multiprotein complex that allows the transfer of genetic information from DNA binding proteins to the RNA polymerase II during transcription initiation. MED12L is a subunit of the kinase module, which is one of the four subcomplexes of the mediator complex. Other subunits of the kinase module have been already implicated in intellectual disability, namely MED12, MED13L, MED13, and CDK19.

methodsWe describe an international cohort of seven affected individuals harboring variants involving MED12L identified by array CGH, exome or genome sequencing.

resultsAll affected individuals presented with intellectual disability and/or developmental delay, including speech impairment. Other features included autism spectrum disorder, aggressive behavior, corpus callosum abnormality, and mild facial morphological features. Three individuals had a MED12L deletion or duplication. The other four individuals harbored single-nucleotide variants (one nonsense, one frameshift, and two splicing variants). Functional analysis confirmed a moderate and significant alteration of RNA synthesis in two individuals.

conclusionOverall data suggest that MED12L haploinsufficiency is responsible for intellectual disability and transcriptional defect. Our findings confirm that the integrity of this kinase module is a critical factor for neurological development.

Indexed as

AdolescentAutism Spectrum DisorderChildChild, PreschoolDevelopmental DisabilitiesExomeFemaleFrameshift MutationHumansIntellectual DisabilityMaleMediator ComplexMutationSequence DeletionTranscription FactorsYoung AdultMED12 protein, humanMediator ComplexTranscription Factorscorpus callosumintellectual disabilityMED12Lmediator complextranscriptional defect

Identifiers

PMID31155615
PMCPMC7243155
OpenAlexW2947890742

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.